Daiichi Sankyo Announces First European Approval for Se. Munich (ots/PRNewswire) – Daiichi Sankyo Europe announced today that Sevikar HCT(R) is now approved in Germany, the first market to launch this new once-daily three-in-one combination product for the treatment of high blood pressure (BP). Read more on Stock World